Completed An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury NCT02063295 Conditions Body Weight, Craniopharyngioma, Hypothalamic Injury, +13 more Locations Children's Hospitals and Clinics of Minnesota — Saint Paul, Minnesota, United States Vanderbilt University Medical Center — Nashville, Tennessee, United States The Boden Institute — Sydney, New South Wales, Australia Austin Health, Metabolic Disorders Centre — Heidelberg Heights, Victoria, Australia View Trial Details
